Risk of MGUS for selected conditions in white and black US male veterans
| . | N . | RR* . | 95% CI . |
|---|---|---|---|
| Total autoimmune | 303 | 1.67 | 1.47-1.90 |
| Autoantibodies detectable | 233 | 1.78 | 1.54-2.06 |
| Systemic involvement | 99 | 1.95 | 1.57-2.42 |
| Polymyositis/dermatomyositis | 5 | 2.39 | 0.89-6.36 |
| Systemic sclerosis | 6 | 4.21 | 1.89-9.38 |
| Organ involvement | 143 | 1.62 | 1.35-1.94 |
| Autoimmune hemolytic anemia | 6 | 2.58 | 1.07-6.20 |
| Pernicious anemia | 14 | 1.97 | 1.16-3.34 |
| Autoantibodies not detectable | 88 | 1.34 | 1.07-1.67 |
| Ankylosing spondylitis | 13 | 2.02 | 1.14-3.56 |
| Total infections | 779 | 1.40 | 1.27-1.53 |
| Influenza | 23 | 1.53 | 1.00-2.33 |
| Pneumonia | 415 | 1.72 | 1.53-1.93 |
| 2 to 4 y prior | 179 | 2.48 | 2.05-3.00 |
| 5 to 9 y prior | 121 | 1.46 | 1.18-1.80 |
| 10 or more y prior | 115 | 1.41 | 1.15-1.73 |
| Hepatitis | 28 | 2.10 | 1.36-3.25 |
| Meningitis | 6 | 1.19 | 0.62-2.28 |
| Septicemia | 78 | 1.32 | 1.02-1.71 |
| Herpes zoster | 25 | 1.70 | 1.11-2.58 |
| Poliomyelitis | 3 | — | — |
| Total inflammatory disorders | 766 | 1.43 | 1.30-1.57 |
| Glomerulonephritis | 78 | 2.62 | 2.06-3.34 |
| Nephrotic syndrome | 38 | 2.68 | 1.68-4.27 |
| Osteoarthritis | 448 | 1.37 | 1.23-1.53 |
| 2 to 4 y prior | 187 | 1.72 | 1.43-2.08 |
| 5 to 9 y prior | 125 | 1.29 | 1.06-1.54 |
| 10 or more y prior | 136 | 1.20 | 0.99-1.45 |
| . | N . | RR* . | 95% CI . |
|---|---|---|---|
| Total autoimmune | 303 | 1.67 | 1.47-1.90 |
| Autoantibodies detectable | 233 | 1.78 | 1.54-2.06 |
| Systemic involvement | 99 | 1.95 | 1.57-2.42 |
| Polymyositis/dermatomyositis | 5 | 2.39 | 0.89-6.36 |
| Systemic sclerosis | 6 | 4.21 | 1.89-9.38 |
| Organ involvement | 143 | 1.62 | 1.35-1.94 |
| Autoimmune hemolytic anemia | 6 | 2.58 | 1.07-6.20 |
| Pernicious anemia | 14 | 1.97 | 1.16-3.34 |
| Autoantibodies not detectable | 88 | 1.34 | 1.07-1.67 |
| Ankylosing spondylitis | 13 | 2.02 | 1.14-3.56 |
| Total infections | 779 | 1.40 | 1.27-1.53 |
| Influenza | 23 | 1.53 | 1.00-2.33 |
| Pneumonia | 415 | 1.72 | 1.53-1.93 |
| 2 to 4 y prior | 179 | 2.48 | 2.05-3.00 |
| 5 to 9 y prior | 121 | 1.46 | 1.18-1.80 |
| 10 or more y prior | 115 | 1.41 | 1.15-1.73 |
| Hepatitis | 28 | 2.10 | 1.36-3.25 |
| Meningitis | 6 | 1.19 | 0.62-2.28 |
| Septicemia | 78 | 1.32 | 1.02-1.71 |
| Herpes zoster | 25 | 1.70 | 1.11-2.58 |
| Poliomyelitis | 3 | — | — |
| Total inflammatory disorders | 766 | 1.43 | 1.30-1.57 |
| Glomerulonephritis | 78 | 2.62 | 2.06-3.34 |
| Nephrotic syndrome | 38 | 2.68 | 1.68-4.27 |
| Osteoarthritis | 448 | 1.37 | 1.23-1.53 |
| 2 to 4 y prior | 187 | 1.72 | 1.43-2.08 |
| 5 to 9 y prior | 125 | 1.29 | 1.06-1.54 |
| 10 or more y prior | 136 | 1.20 | 0.99-1.45 |
— indicates RR and CI not calculated due to small numbers.
RR adjusted for number of visits, race, latency, attained age, and calendar time.